Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 17,971 shares at $43.64 ($785K) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Open-market sale of $785k EWTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.64 | 8,782 | $383K | 48.8% |
| 2 | $43.66 | 8,276 | $361K | 46.0% |
| 3 | $44.33 | 913 | $40K | 5.2% |
| Total | $43.68 avg | 17,971 | $785K | 100% |
| Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $119K | — | Filing → |